THURSDAY, OCTOBER 19, 2017

Study shows Ebola survivors treated in clinics struggle with additional health problems

A recent study in Sierra Leone showed surviving Ebola patients who were treated in care clinics struggle with long-term health problems. Read More »

Buffalo researcher explores attitudes and emotions surrounding Ebola

Janet Ying, of the University of Buffalo, is leading a study that suggests there is more to Ebola than illness: tangled in the matrices of disease and prevention is perception of risk and risk’s influence on emotion and behavior. Read More »

Research links dromedary camels to MERS coronavirus

A international research team is advancing work that proves the Middle Eastern dromedary camel transmits several strains of MERS coronavirus. Read More »

Two new studies explore containment options for camel-transmitted MERS

While camels are useful and beloved creatures, they also harbor the ability to transmit to humans communicable forms of MERS coronavirus. Read More »

Malaysian macaque monkeys present malaria risk to humans

Malaysian macaque monkeys, common in region-specific forests, have become a vector for malaria among humans, according to the London School of Hygiene and Tropical Medicine. Read More »

Harvard Medical School, Children's Hospital investigate effects of initial influenza infection

Harvard Medical School, together with Children’s Hospital, is at work on research that could indicate lasting effects left by the initial incidence of an influenza infection. Read More »

Asian Development Bank explains benefits of treating malaria via RMTF

The Asian Development Bank has detailed the positive effects of treating malaria through Regional Malaria and Other Communicable Disease Threats Trust Fund (RMTF). Read More »

Minnesota health department releases vaccine announcement update

The Minnesota Department of Health has announced revisions to its policy of vaccine replenishment after existing supplies are exhausted. Read More »

February predicted as peak of flu season

Forecast models released Dec. 15 by the Centers for Disease Control (CDC) indicate the apex of flu season will likely occur nationwide in February. Read More »

Researchers investigate vaccine options for common diseases

Researchers at the University of Washington and the University of Texas at Galveston are exploring the ways receptor sites in cells bind to disease and vaccine particles. Read More »

WHO optimistic for future elimination of malaria

The WHO estimates that cases of malaria have decreased in surveyed countries to the point that elimination of the disease may be possible. Read More »

Joint research group studies common flu strains

Researchers are studying statistical variations of blood samples across all age ranges, looking for immune signatures or markers of vaccines, which may indicate vaccine effectiveness against common strains of flu. Read More »

Scripps researchers study antibodies that fight HIV

Researchers at The Scripps Research Institute (TSRI) are studying the origins and ways antibodies that fight HIV develop, interact and fight HIV. Read More »

NIH outlines strategic plan, initiatives for 2016

NIH has published its strategic plan and initiatives for 2016 as a result of the solicitation of NIH advisory councils. Read More »

Stanford University researchers detail cellular marker discovery

Researchers at Stanford University have discovered a set of cellular markers that distinguish between patients with types of viral infections and those with types of bacterial infections. Read More »

Inactivated polio vaccine now available in India

Indian Union Minister for Health and Family Welfare Shri J.P. Nadda, announced Dec. 21 that an inactivated polio vaccine (IPV) is widely available in India and around the world. The vaccine, which contains live but inactive antibodies that trigger an immune response in those receiving the vaccine, is one of the most recent treatments against polio.  Read More »

USAID issues call for HIV/AIDS vaccine grant proposals

USAID has issued a call for grant proposals as of Dec. 11 for those interested in furthering research on vaccines for treatment of HIV/AIDS. The grant must focus upon vaccine engineering and development for treating HIV/AIDS, and may specialize in particular upon women infected with HIV/AIDS. The target population for the grant and research is not limited to the U.S. Read More »

Abivax announces clinical trail for HIV/AIDS vaccine

Abivax, a French pharmaceutical manufacturer, announced Dec. 21 the clinical trial of HIV/AIDS vaccine ABX464 is available. The drug “is an orally available small molecule inhibiting HIV replication through an entirely novel mechanism, which may confer significant advantages over competing drugs," Abivax Chief Executive Officer Dr. Harmut Ehrlich said. Read More »

European health officials release Ebola update

The European Centre for Disease Prevention and Control recently provided an update on the ongoing Ebola outbreak in West Africa while pointing out the importance of maintaining surveillance and immediate response abilities in the countries originally affected by the virus. The center said that as of Nov. 18, there had been 28,598 cases of Ebola virus disease related to the outbreak. Read More »

US announces initiative to combat multidrug-resistant TB

The White House announced the creation of The National Action Plan to Combat Multidrug-Resistant Tuberculosis, an initiative to target the strain of TB that has proved resistant to common courses of drug therapy and affects countries worldwide. With this initiative, attention is given to particular types of TB in a time when it has become treatable and is in decline. Read More »